Karen L. Reckamp

Nov 13, 2024 | cancernetwork.com | Hatim Husain |Karen L. Reckamp

November 13, 2024By OncologyONCOLOGY Vol 38, Issue 11Pages: 444-446Personalized therapy for non–small cell lung cancer has evolved significantly with the advent of comprehensive molecular testing.

Aug 21, 2024 | onclive.com | Karen L. Reckamp

CommentaryVideoAugust 21, 2024Author(s):Karen L. Reckamp, MD, MS, discusses emerging EGFR TKIs in EGFR Exon 20–Mutated NSCLC. Karen L. Reckamp, MD, MS, director, Division of Medical Oncology, associate director, Clinical Research, medical oncology director, Lung Institute, Cedars-Sinai, discusses emerging data for next-generation EGFR TKIs in the treatment of patients with non–small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion mutations.

Jul 26, 2024 | onclive.com | Karen L. Reckamp

Karen L. Reckamp, MD, MS, professor of medicine, director, Division of Medical Oncology and Lung Institute, Cedars-Sinai Medical Center, associate director, Clinical Research, Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, discusses the role of amivantamab-vmjw (Rybrevant) in the treatment of patients with non–small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion mutations.

Jun 20, 2024 | onclive.com | Karen L. Reckamp

Welcome to OncLive On Air®! I’m your host today, Ashling Wahner. OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions. In today’s episode, sponsored by Cedars-Sinai Medical Center, we had the pleasure of speaking with Karen L.

Sep 13, 2023 | onclive.com | Edward Kim |Heather Wakelee |Karen L. Reckamp |Edgardo S. Santos |Lyudmila A Bazhenova

During the 2023 International Lung Cancer Congress, OncLive® asked experts from the lung cancer field to discuss the challenges of the ongoing cisplatin and carboplatin shortages in the United States and detail how they are adapting in their practices. These experts included:Karen L.